osimertinib
astrazeneca
['lung', 'nsclc', 'lcsm,(-blcsm)', 'sclc', 'osimertinib']
. shares compelling new survival data for the use of osimertinib in the earliest stages of non-small cell lung cancer at #asco23. #nsclc #lcsm 
Yale Cancer Center is a collaboration between renowned cancer researchers and physicians @Yale and @SmilowCancer.